Carla Kriwet - ROYPHILIPS President
| PHI1 Stock | EUR 25.90 0.05 0.19% |
President
Dr. Carla Kriwet has served as Executive Vice President, Chief Business Leader Connected Care Health Informatics at Koninklijke Philips N.V. since February 2017. Previously, she led the Business Group PCMS. Carla has successfully driven growth and innovation in PCMS. Before this role she led our market in Germany, Switzerland and Austria to greater growth and profitability. Prior to joining Philips in 2013 she was Chief Sales Marketing Officer and Member of the Global Executive Board at Draegerwerk AG Co KGaA, a Germanbased engineering and medical technology firm. Before that, she enjoyed multiple leadership roles at Linde AG, Germany, and was a Senior Principal at The Boston Consulting Group. She is Vice Chairman of the Supervisory Board of Zeiss Meditec AG, and Vice Chairman of the Supervisory Board of Save the Children, Germany, which focuses on childrens rights, health, education and emergency relief. Carla graduated in Business Studies at the University of St. Gallen, Switzerland. She holds a PhD in Inter and intraorganizational knowledge transfer from the University of St. Gallen, Switzerland and University of Tokyo, Japan. since 2017.
| Age | 47 |
| Tenure | 7 years |
ROYPHILIPS Leadership Team
Elected by the shareholders, the ROYPHILIPS's board of directors comprises two types of representatives: ROYPHILIPS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ROYPHILIPS. The board's role is to monitor ROYPHILIPS's management team and ensure that shareholders' interests are well served. ROYPHILIPS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ROYPHILIPS's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marnix Ginneken, Executive Vice President Chief Legal Officer, Member of the Executive Board, Secretary | ||
| Christine Poon, Independent Vice Chairman of the Supervisory Board, Secretary | ||
| Robert Cascella, Executive Vice President | ||
| Neelam Dhawan, Independent Member of the Supervisory Board | ||
| Henk Jong, Executive Vice President Chief of International Markets | ||
| A Harrison, Independent Member of the Supervisory Board | ||
| Andy Ho, Executive Vice President, Chief Market Leader of Philips Greater China | ||
| Roy Jakobs, Executive Vice President Chief Business Leader - Personal Health | ||
| M Doherty, Independent Member of the Shariah Supervisory Board | ||
| Orit Gadiesh, Independent Member of the Supervisory Board | ||
| Jeroen Tas, Executive Vice President Chief Innovation and Strategy Officer | ||
| Bert Meurs, Executive Vice President - Chief Business Leader | ||
| Deeptha Khanna, Chief Business Leader of Personal Health Businesses | ||
| Vitor Rocha, Executive Vice President Market Leader - Philips North America | ||
| Sophie Bechu, Executive Vice President, Chief Operating Officer | ||
| Paulus Stoffels, Independent Member of the Supervisory Board | ||
| Francois Houten, President CEO and Chairman of the Board of Management and Executive Committee | ||
| Edwin Paalvast, Chief of International Markets | ||
| Jeroen Veer, Independent Chairman of the Supervisory Board | ||
| Abhijit Bhattacharya, Executive Vice President & Chief Financial Officer, Member of the Management Board | ||
| Carla Kriwet, Executive Vice President Chief Business Leader of Connected Care & Health Informatics (CCHI) Businesses | ||
| Daniela Seabrook, Chief Human Resource Officer, Executive Vice President | ||
| David Pyott, Independent Member of the Supervisory Board |
ROYPHILIPS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ROYPHILIPS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 18.73 B | |||
| Price To Book | 0.81 X | |||
| Price To Sales | 0.69 X | |||
| Revenue | 17.83 B | |||
| EBITDA | 115 M | |||
| Net Income | (1.61 B) | |||
| Total Debt | 6.17 B | |||
| Cash Flow From Operations | (173 M) | |||
| Price To Earnings To Growth | 2.83 X | |||
| Number Of Employees | 39 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in ROYPHILIPS Stock
ROYPHILIPS financial ratios help investors to determine whether ROYPHILIPS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ROYPHILIPS with respect to the benefits of owning ROYPHILIPS security.